Sinopharm

China National Pharmaceutical Group Co., Ltd. is a large pharmaceutical and health industry group directly managed by the State-owned Assets Supervision and Administration Commission of the State Council. Its business extensively covers the entire industrial chain of pharmaceutical research and development, production, distribution, medical devices, and medical services. It brings together many well-known enterprises and scientific research institutions, possessing strong scientific research and innovation capabilities, with fruitful achievements in new drug development and generic drug production. In the field of pharmaceutical distribution, it has built a vast sales network to ensure the stability and safety of drug supply. It actively participates in domestic and international pharmaceutical cooperation and exchange, promoting the internationalization of China's pharmaceutical industry, and plays an extremely important leading role in safeguarding public health and promoting the development of the pharmaceutical industry.